tiprankstipranks
Trending News
More News >
Jade Biosciences (JBIO)
NASDAQ:JBIO
US Market

Jade Biosciences (JBIO) Financial Statements

Compare
178 Followers

Jade Biosciences Financial Overview

Jade Biosciences's market cap is currently $736.07M. The company's EPS TTM is $-0.48; its P/E ratio is -1.41; and it has a dividend yield of 14.68%. Jade Biosciences is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -282.00K$ -96.00K$ -68.00K$ -15.00K$ -1.00K
Operating Income$ -74.60M$ -81.41M$ -53.24M$ -23.02M$ -8.89M
EBITDA$ -69.29M$ -75.37M$ -51.42M$ -22.95M$ -9.54M
Net Income$ -69.63M$ -75.52M$ -51.51M$ -22.96M$ -9.61M
Balance Sheet
Cash & Short-Term Investments$ 78.62M$ 122.44M$ 129.22M$ 167.38M$ 4.57M
Total Assets$ 80.33M$ 127.42M$ 135.30M$ 175.36M$ 4.71M
Total Debt$ 417.00K$ 675.00K$ 1.09M$ 574.00K$ 0.00
Net Debt$ -33.33M$ -22.82M$ -21.31M$ -53.62M$ -4.57M
Total Liabilities$ 3.90M$ 17.96M$ 8.56M$ 2.94M$ 1.77M
Stockholders' Equity$ 76.43M$ 109.46M$ 126.74M$ 172.42M$ 2.94M
Cash Flow
Free Cash Flow$ -71.20M$ -56.92M$ -39.32M$ -27.58M$ -7.86M
Operating Cash Flow$ -71.20M$ -56.78M$ -39.12M$ -27.40M$ -7.86M
Investing Cash Flow$ 56.03M$ 11.88M$ 6.93M$ -113.43M$ 0.00
Financing Cash Flow$ 25.43M$ 46.00M$ 396.00K$ 190.46M$ 8.92M
Currency in USD

Jade Biosciences Earnings and Revenue History

Jade Biosciences Debt to Assets

Jade Biosciences Cash Flow

Jade Biosciences Forecast EPS vs Actual EPS